Mechanism of microRNA-223-3p inhibiting hepatic stellate cell activation by targeting microtubule-associated protein 1B
10.3969/j.issn.1001-5256.2023.12.015
- VernacularTitle:microRNA-223-3p靶向微管相关蛋白1B抑制肝星状细胞活化的机制研究
- Author:
Wentao XIE
1
;
Kangkang YU
1
;
Qi CHENG
1
;
Ning LI
1
Author Information
1. Department of Infectious Diseases， Huashan Hospital， Fudan University； Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response； National Medical Center for Infectious Diseases， Shanghai 200040， China
- Publication Type:Journal Article
- Keywords:
Hepatic Fibrosis;
Microtubule-Associated Proteins;
Hepatic Stellate Cells;
MicroRNAs
- From:
Journal of Clinical Hepatology
2023;39(12):2845-2850
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the effect of microRNA-223-3p （miR-223-3p） on hepatic stellate cell （HSC） activation and its mechanism. MethodsHuman HSC LX2 cells were selected for the study， and LX2 cells were stimulated by TGF-β to establish a model of HSC activation； quantitative real-time PCR was used to measure the change in the expression level of miR-223-3p during HSC activation. After LX2 cells were transfected with miR-223-3p mimic， quantitative real-time PCR， Western blot， and immunofluorescence assay were used to clarify the regulatory effect of miR-223-3p on HSC activation， and dual-luciferase reporter assay was used to verify the association between miR-223-3p and the target gene MAP1B. After LX2 cells were transfected with MAP1B siRNA， Western blot was used to clarify the influence of inhibiting MAP1B expression on HSC activation； after LX2 cells were transfected with miR-223-3p， quantitative real-time PCR and Western blot were used to verify the regulatory effect of miR-223-3p on MAP1B. The independent-samples t test was used for comparison of continuous data between two groups. ResultsHSC in the activated state had a significant reduction in the expression level of miR-223-3p compared with those in the resting state （t=9.12， P<0.001）. Overexpression of miR-223-3p inhibited the mRNA and protein expression levels of the markers for HSC activation alpha-smooth muscle actin and collagen type Ⅰ （mRNA expression： t=8.35 and 12.23， both P<0.01； protein expression： t=16.24 and 20.90， both P<0.001）. The dual-luciferase reporter assay confirmed that MAP1B was a potential target gene of miR-223-3p. Compared with the control group， LX2 cells with miR-223-3p overexpression had significant reductions in the mRNA and protein expression levels of MAP1B （mRNA expression： t=5.95， P<0.01； protein expression： t=11.12， P<0.001）. ConclusionThis study shows that miR-223-3p can inhibit HSC activation by targeting MAP1B.
